Main navigation | Main content
Whether your business is pharmaceuticals, medical devices, transportation or food science, investing in sponsored research with the University of Minnesota’s Minnesota Innovation Partnerships—or MN-IP—can significantly increase your company’s competitive edge and improve its bottom line.
Known nationally as the "Minnesota model" for its groundbreaking approach, MN-IP allows companies to pay a low, one-time, upfront fee and receive an exclusive worldwide license to intellectual property (IP) arising from sponsored research. Companies control all patent filings associated with the technology developed during the research project. And, they are free to sublicense the technology at any time.
Companies sponsoring research at the university can still choose to negotiate a license deal after the IP is developed, but MN-IP eliminates the uncertainty of protracted negotiations—negotiations that could hold up development in a highly competitive market.
With MN-IP, when the technology is ready to go, companies are holding the low, pre-set terms in their hands.
The first MN-IP project to result in a license deal is now on track to have a major impact on the growing composite materials industry.
Adama Materials, a startup company launched to commercialize the technology, worked with an interdisciplinary team of U of M researchers to develop new techniques for making stronger and less costly composites, the materials used in the high performance plastics industry.
CEO, Adama Materials, Inc.